Brief: Proqr Announces Q3 2022 Operating And Financial Results
Nov 9 (Reuters) - Proqr Therapeutics Nv PRQR.O :
* PROQR ANNOUNCES THIRD QUARTER 2022 OPERATING AND FINANCIAL
RESULTS
* QTRLY LOSS PER SHARE EUR 0.34
* REPAYMENT OF DEBT WITH CASH RUNWAY INTO 2026
* Q3 EARNINGS PER SHARE VIEW EUR -0.21 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX26Y502
Further company coverage: PRQR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ProQR Therapeutics NV
See all newsProQR Therapeutics NV reports results for the quarter ended June 30 - Earnings Summary
ProQR Q2 revenue more than doubles
Brief: ProQR Therapeutics Q2 EPS EUR -0.08
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview
ProQR Therapeutics NV expected to post a loss of 11 cents a share - Earnings Preview